本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

神经分泌生物科学

139.60
+0.66000.48%
盘后139.600.00000.00%16:10 EDT
成交量:50.37万
成交额:7,007.31万
市值:138.46亿
市盈率:41.17
高:140.03
开:139.00
低:138.08
收:138.94
52周最高:154.61
52周最低:84.23
股本:9,918.15万
流通股本:9,800.26万
量比:0.75
换手率:0.51%
股息:- -
股息率:- -
每股收益(TTM):3.39
每股收益(LYR):3.40
净资产收益率:13.39%
总资产收益率:8.67%
市净率:5.14
市盈率(LYR):41.07

数据加载中...

2025/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/27

重要事件披露

Form 8-K - Current report